News

ContextVision to Exhibit Image Enhancement Product Updates at ITEM 2017


Posted on April 12th, by Lilian Arvedson in Home, News. Comments Off on ContextVision to Exhibit Image Enhancement Product Updates at ITEM 2017

STOCKHOLM – April 12, 2017 – ContextVision will demonstrate its leading medical imaging enhancement software solutions at the International Technical Exhibition of Medical Imaging 2017 (ITEM) April 14-16 at the Pacifico Yokohama Convention Center in Tokyo.

The following product updates will be available for demonstration:

  • US PLUSView™ 2.0 on iOS – The world’s leading 2D image enhancement technology has been extended for implementation on the iOS platform, addressing the growing market for patient care and making ultrasound examinations accessible and affordable to more users outside traditional clinics.
  • GOPView XR2Plus with extended OEM Tuning Tool – ContextVision’s gold standard image enhancement solution for digital radiography now offers x-ray system manufacturers the utmost tuning flexibility in parameter optimization to satisfy various preferences. The tuning tool allows for quick fine-tuning, enabling a fast and precise workflow by making images easier to read.

“ContextVision continues to broaden our product portfolio to give customers high-quality products. We are dedicated to ensuring the best image quality for multiple modalities,” said Fredrik Palm, vice president, ContextVision. “We know that image quality continues to be of great importance for radiologists and we continue to innovate to further enhance the clinical value of medical imaging.”

For product demonstrations, visit ContextVision at booth 416. Read more information on our partners website Toyo Corporation

About ContextVision
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology, and is investing significantly in the field to expand the company’s product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV.





Comments are closed.